{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:56:01Z","timestamp":1787500561245,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bioorg.2021.105154","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:46:11Z","timestamp":1625665571000},"page":"105154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma"],"prefix":"10.1016","volume":"114","author":[{"given":"Xiaohong","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiedan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaixiu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bioorg.2021.105154_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105154_b0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrclinonc.2014.122","article-title":"Treatment of intermediate-stage hepatocellular carcinoma","volume":"11","author":"Forner","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105154_b0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/hep-2016-0004","article-title":"Immune checkpoint inhibitors for hepatocellular carcinoma","volume":"3","author":"Bonilla-Reyes","year":"2016","journal-title":"Hepat. Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105154_b0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.21037\/tcr.2018.05.20","article-title":"Mechanisms of resistance to chemotherapy and radiotherapy in hepatocellular carcinoma","volume":"7","author":"Guo","year":"2018","journal-title":"Translational Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105154_b0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41416-019-0482-x","article-title":"M2 macrophages mediate sorafenib resistance by secreting HGF in a feed-forward manner in hepatocellular carcinoma","volume":"121","author":"Dong","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2021.105154_b0030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000496439","article-title":"Systemic Treatment for Advanced Hepatocellular Carcinoma","volume":"8","author":"Bouattour","year":"2019","journal-title":"Liver Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105154_b0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s10637-019-00801-8","article-title":"Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan","volume":"38","author":"Ogasawara","year":"2020","journal-title":"Invest. New Drugs"},{"issue":"10","key":"10.1016\/j.bioorg.2021.105154_b0040","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/cancers12102863","article-title":"Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II","volume":"12","author":"Molinaro","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105154_b0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105154_b0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bioorg.2021.105154_b0055","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.3390\/cells9092027","article-title":"Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers","volume":"9","author":"Kaps","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2021.105154_b0060","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2020.12.015","article-title":"Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production","volume":"160","author":"Myojin","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105154_b0065","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","article-title":"Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma","volume":"184","author":"Sun","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105154_b0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7150\/thno.46124","article-title":"Extracellular-vesicles delivered tumor-specific sequential nanocatalysts can be used for MRI-informed nanocatalytic Therapy of hepatocellular carcinoma","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.bioorg.2021.105154_b0075","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1039\/C4NP00064A","article-title":"Natural product and natural product derived drugs in clinical trials","volume":"31","author":"Butler","year":"2014","journal-title":"Nat. Prod. Rep."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105154_b0080","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.apsb.2019.11.011","article-title":"Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity","volume":"10","author":"Huang","year":"2020","journal-title":"Acta Pharm. Sin B"},{"issue":"21","key":"10.1016\/j.bioorg.2021.105154_b0085","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1021\/jm100387d","article-title":"Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents","volume":"53","author":"Dong","year":"2010","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105154_b0090","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10637-018-0702-x","article-title":"A mediator of phosphorylated Smad2\/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells","volume":"37","author":"Yang","year":"2019","journal-title":"Invest. New Drugs"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105154_b0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11418-017-1122-5","article-title":"Evodiamine ameliorates liver fibrosis in rats via TGF-beta1\/Smad signaling pathway","volume":"72","author":"Yang","year":"2018","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bioorg.2021.105154_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153180","article-title":"Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases","volume":"68","author":"Li","year":"2020","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105154_b0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.chmed.2019.06.003","article-title":"Pharmacokinetic studies of multi-bioactive components in rat plasma after oral administration of Xintiantai \u2160 extract and effects of guide drug borneol on pharmacokinetics","volume":"12","author":"Liang","year":"2020","journal-title":"Chinese Herbal Med."},{"key":"10.1016\/j.bioorg.2021.105154_b0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fphar.2018.00130","article-title":"Characterization of the in Vitro Metabolic Profile of Evodiamine in Human Liver Microsomes and Hepatocytes by UHPLC-Q Exactive Mass Spectrometer","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2021.105154_b0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.aca.2005.11.045","article-title":"Determination and pharmacokinetics of evodiamine in the plasma and feces of conscious rats","volume":"558","author":"Shyr","year":"2006","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.bioorg.2021.105154_b0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jchromb.2012.03.036","article-title":"Simultaneous determination of six alkaloids and one monoterpene in rat plasma by liquid chromatography-tandem mass spectrometry and pharmacokinetic study after oral administration of a Chinese medicine Wuji Pill","volume":"895\u2013896","author":"Yuan","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105154_b0125","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/acs.jmedchem.9b01626","article-title":"Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105154_b0130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2018.04.009","article-title":"Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties","volume":"151","author":"Hu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2021.105154_b0135","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1021\/acs.jmedchem.5b00910","article-title":"Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents","volume":"58","author":"Wang","year":"2015","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2021.105154_b0140","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1021\/jm300605m","article-title":"New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations","volume":"55","author":"Dong","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105154_b0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmech.2019.03.034","article-title":"A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade","volume":"171","author":"Liang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2021.105154_b0150","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1021\/acs.jmedchem.0c00983","article-title":"Discovery of Evodiamine Derivatives as Highly Selective PDE5 Inhibitors Targeting a Unique Allosteric Pocket","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105154_b0155","first-page":"93","article-title":"Yuankun Zhang, Lu Jia and Guanghui Liu, New tricks for an old dog: discovery, synthesis, in vitro and in vivo antitumor evaluation as well as docking studies of novel rutaecarpine derivatives as Topoisomerase I inhibitors","volume":"7","author":"Yingjie Zhang","year":"2015","journal-title":"J. Chem. Pharm. Res."},{"issue":"21","key":"10.1016\/j.bioorg.2021.105154_b0160","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1039\/C9CC00434C","article-title":"A concise synthesis and biological study of evodiamine and its analogues","volume":"55","author":"Deng","year":"2019","journal-title":"Chem. Commun. (Camb.)"},{"issue":"41","key":"10.1016\/j.bioorg.2021.105154_b0165","doi-asserted-by":"crossref","first-page":"14666","DOI":"10.1002\/anie.201906112","article-title":"Light-Driven Intramolecular C-N Cross-Coupling via a Long-Lived Photoactive Photoisomer Complex","volume":"58","author":"Jing","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2021.105154_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104828","article-title":"Design, synthesis and antitumor activity evaluation of Chrysamide B derivatives","volume":"111","author":"Zhu","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105154_b0175","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3892\/ol.2020.12095","article-title":"High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis","volume":"20","author":"Cai","year":"2020","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105154_b0180","doi-asserted-by":"crossref","first-page":"12791","DOI":"10.1007\/s13277-016-5251-3","article-title":"Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting beta-catenin-mediated angiogenesis","volume":"37","author":"Shi","year":"2016","journal-title":"Tumour Biol."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105154_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092027","article-title":"Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers","volume":"9","author":"Kaps","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2021.105154_b0190","doi-asserted-by":"crossref","first-page":"57243","DOI":"10.7554\/eLife.57243","article-title":"Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy","volume":"9","author":"Barrett","year":"2020","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.bioorg.2021.105154_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071723","article-title":"The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma","volume":"20","author":"Baglieri","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.bioorg.2021.105154_b0200","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.7150\/ijbs.45446","article-title":"Cancer-associated Fibroblasts induce epithelial-mesenchymal transition via the Transglutaminase 2-dependent IL-6\/IL6R\/STAT3 axis in Hepatocellular Carcinoma","volume":"16","author":"Jia","year":"2020","journal-title":"Int. J. Biol. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821005319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821005319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:32:12Z","timestamp":1758616332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821005319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":40,"alternative-id":["S0045206821005319"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105154","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105154"}}